Minerva Neurosciences (NERV) Return on Equity (2016 - 2026)
Minerva Neurosciences filings provide 2 years of Return on Equity readings, the most recent being 0.03% for Q4 2021.
- On a quarterly basis, Return on Equity fell 3.0% to 0.03% in Q4 2021 year-over-year; TTM through Dec 2021 was 0.03%, a 3.0% decrease, with the full-year FY2021 number at 0.02%, down 2.0% from a year prior.
- Return on Equity hit 0.03% in Q4 2021 for Minerva Neurosciences, down from 0.01% in the prior quarter.
- In the past five years, Return on Equity ranged from a high of 0.0% in Q3 2020 to a low of 0.03% in Q4 2021.